< Back to latest news & events

News

HGF ranked Gold in the FT special report – Europe’s Leading Patent Law Firms 2023

June 2023

HGF has been ranked in the ‘Gold’ and ‘Silver’ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on the 14th June 2023. The firm is delighted to be ranked for the 5th consecutive year since the guide was established in 2019.

More than 10,000 patent attorneys working in patent law firms or in the patent departments of companies, as well as clients, were directly invited to take part in the survey. Survey participants could recommend firms both in general and by specialities, categorised into six sectors. The sample was collected via research conducted by Statista on relevant company websites, in publications and from the EPI (the Institute of Professional Representatives Before the European Patent Office), the professional body representing European patent attorneys.

The firm is one of the leading firms of IP specialists in Europe, with 23 offices across the UK, Germany, The Netherlands, Switzerland, Austria, France and Ireland, and is internationally recognised by its peers across these core areas of technology.

HGF has been ranked Gold” very frequently recommended” for:

  • Biotechnology & Food
  • Chemistry & Pharmaceuticals
  • Electrical Engineering
  • Mechanical Engineering
  • IT & Software

Silver for “frequently recommended” for:

  • Materials & Nanotechnology

Lucy Johnson, Head of the Engineering team commented, “We are delighted. Receiving a gold ranking from our clients and peers is a reflection of the exceptional quality of the HGF Engineering team across Europe. The team has a wealth of technical and in-house experience enabling us to provide strategic and relevant IP advice across the Engineering landscape. Our work and reputation in the energy, medical technology and automotive sectors, in particular is key to continuing to grow and develop our client partnerships.”

Kate Taylor, Head of the Life Sciences team commented, “We are delighted that the exceptional technical and legal knowledge of the HGF life sciences team has been recognised by this ranking.”

Dr Chris Benson, Head of the Electronics team commented, “I’m very pleased that the excellence of our attorneys in the electronics and computing field has been recognised.   It is especially pleasing to have been awarded a gold ranking which is awarded based on client recognition.  The HGF Electronics group handles a wide variety of subject matter in the electronics and computing field. Of note is the exceptional track record of handling oppositions relating to standards-based technologies such as video coding and telecommunication technologies as well as standards mapping.”

Dr Andrew Wells, Head of the Chemistry team commented, “I’m delighted that our excellent reputation in the chemistry field has been recognised. This is an excellent achievement for the HGF Chemistry team and for HGF as a whole. We have a large team of chemical patent attorneys located throughout Europe and we pride ourselves on providing commercially relevant and strategic IP advice to our clients.  We cover the whole chemistry landscape and have seen significant growth in the key areas of pharmaceuticals, formulation science, materials science, agrochemicals, process chemistry, fuel cells and electrochemistry. We also have a significant European oppositions practice that continues to go from strength to strength.”

As one of Europe’s leading firms we are committed to building strong client relationships and delivering outstanding service from our offices in Germany, The Netherlands, Switzerland, Austria, France, Ireland and the UK. We continue to deepen our understanding of the client experience and provide tailor made solutions for our clients in Europe and around the world. We are delighted to have been ranked in Gold and Silver, and believe it is our integrated approach providing multidisciplinary teams of patent attorneys, trade mark attorneys, and IP solicitors; each guided by the great value we place on People, Teamwork, Excellence and Progressive.

For the full report see here:

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article